111 related articles for article (PubMed ID: 11114748)
21. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
22. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
23. New targeted therapies for gastric cancer.
Asaoka Y; Ikenoue T; Koike K
Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
[TBL] [Abstract][Full Text] [Related]
24. [Necessity of chip technology in stomach cancer].
Galamb O; Sipos F; Molnár B; Tulassay Z
Orv Hetil; 2004 May; 145(18):939-47. PubMed ID: 15188640
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
Wong LL; Chang CF; Koay ES; Zhang D
Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
[TBL] [Abstract][Full Text] [Related]
26. Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.
Grabsch HI; Askham JM; Morrison EE; Pomjanski N; Lickvers K; Parsons WJ; Boecking A; Gabbert HE; Mueller W
J Pathol; 2004 Feb; 202(2):208-14. PubMed ID: 14743503
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas.
Lee SH; Jeong EG; Nam SW; Lee JY; Yoo NJ; Lee SH
Pathology; 2007 Jun; 39(3):326-9. PubMed ID: 17558859
[TBL] [Abstract][Full Text] [Related]
28. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
Kim KK; Lee JJ; Yang Y; You KH; Lee JH
Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
[TBL] [Abstract][Full Text] [Related]
29. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer.
Yamagishi M; Noda M; Tatsumi Y; Mukaisho K; Mitsufuji S; Sugihara H; Okanoue T; Hattori T
J Gastroenterol; 2004 Dec; 39(12):1143-9. PubMed ID: 15622477
[TBL] [Abstract][Full Text] [Related]
30. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens.
Yasui W; Oue N; Sentani K; Sakamoto N; Motoshita J
Pathol Int; 2009 Mar; 59(3):121-36. PubMed ID: 19261089
[TBL] [Abstract][Full Text] [Related]
31. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
32. Human gastric cancer kinase profile and prognostic significance of MKK4 kinase.
Wu CW; Li AF; Chi CW; Huang CL; Shen KH; Liu WY; Lin W
Am J Pathol; 2000 Jun; 156(6):2007-15. PubMed ID: 10854223
[TBL] [Abstract][Full Text] [Related]
33. tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer.
Lin WC; Li AF; Chi CW; Chung WW; Huang CL; Lui WY; Kung HJ; Wu CW
Clin Cancer Res; 1999 Jul; 5(7):1745-51. PubMed ID: 10430078
[TBL] [Abstract][Full Text] [Related]
34. Genetics of gastric cancer.
Peddanna N; Holt S; Verma RS
Anticancer Res; 1995; 15(5B):2055-64. PubMed ID: 8572602
[TBL] [Abstract][Full Text] [Related]
35. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology of gastric cancer.
Cervantes A; Rodríguez Braun E; Pérez Fidalgo A; Chirivella González I
Clin Transl Oncol; 2007 Apr; 9(4):208-15. PubMed ID: 17462972
[TBL] [Abstract][Full Text] [Related]
37. [Molecular diagnosis of gastric cancer].
Yasui W; Oue N; Kuraoka K; Nakayama H
Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):463-7. PubMed ID: 12094696
[TBL] [Abstract][Full Text] [Related]
38. No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell lines.
Shao RX; Otsuka M; Kato N; Chang JH; Muroyama R; Taniguchi H; Moriyama M; Wang Y; Kawabe T; Omata M
J Gastroenterol; 2005 Sep; 40(9):918. PubMed ID: 16211354
[No Abstract] [Full Text] [Related]
39. [Carcinoma of the stomach].
Vukobrat-Bijedić Z
Med Arh; 2003; 57(1 Suppl 2):81-3. PubMed ID: 15137240
[TBL] [Abstract][Full Text] [Related]
40. [Gastric cancer: a unique etiological entity?].
Pepper I; Acuña M
Rev Med Chil; 1997 Jan; 125(1):107-12. PubMed ID: 9336078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
